Proud to Join the SME Climate Hub: Committing to A...
We’re thrilled to join the SME Climate Hub community, committing to halve our emissions by 2030. Together, we're taking authentic action towards ...
We’re thrilled to join the SME Climate Hub community, committing to halve our emissions by 2030. Together, we're taking authentic action towards ...
The French law on the freedom to choose one’s professional future of September 5, 2018 makes equal pay for men and women an obligation of result...
Developed by Quinten in 2022, AliBERT is a specialized model focusing on the French biomedical language. One version has been released as an open-s...
A successful proof-of-concept for AliBERT, the first French-language model specialized in the biomedical field. In partnership with a major French ...
Gaucher disease is a rare inherited lysosomal storage disorder (LSD) which mainly leads to hepatosplenomegaly, anemia, thrombocytopenia, bone lesio...
Quinten Health is delighted to announce its participation to the first “Life Sciences in the Nordic countries ” mission launched by Bpifrance ...
Alexandre Templier, President of Quinten Health, was invited last Thursday by Norbert Nabet (Ziwig Biotech) to take part in a round table...
Quinten Health is participating in the More-EUROPA project in the framework of the Horizon Europe program. The latter funds projects aiming to...
Quinten Health is certified by the European Health Data & Evidence Network (EHDEN) Consortium after their fourth and final call ! This...
From Data to Artificial Intelligence in healthcareFollowing Part 5: The future of pharma 6) From Data to Artificial Intelligence Big Data will...